CROWD-ASPECT
Phase 1
Recruiting
- Conditions
- Heart failureTherapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
- Registration Number
- CTIS2022-502239-20-00
- Lead Sponsor
- Bispebjerg Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 7200
Inclusion Criteria
Patients who are registered in the Danish Heart Failure Registry with reduced ejection fraction who have claimed at least one prescription for an aldosterone antagonist
Exclusion Criteria
Patients who had filled in a prescription for an aldosterone antagonist before the date of first registered visit in the Danish Heart Failure Registry and patients who have opted out of the study
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method